CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,570,000 | +32.0% | 850,000 | +88.9% | 1.98% | +44.3% |
| Q4 2022 | $2,704,500 | +8.8% | 450,000 | +5.4% | 1.37% | +50.8% |
| Q3 2022 | $2,485,000 | +77.5% | 427,000 | +42.4% | 0.91% | +94.2% |
| Q1 2022 | $1,400,000 | -74.2% | 299,800 | -86.3% | 0.47% | -68.6% |
| Q4 2021 | $5,419,000 | -44.6% | 2,185,000 | -34.0% | 1.49% | -41.7% |
| Q3 2021 | $9,773,000 | +6.3% | 3,313,000 | -9.9% | 2.56% | +20.2% |
| Q2 2021 | $9,197,000 | +436.6% | 3,678,677 | +524.6% | 2.13% | +348.1% |
| Q1 2021 | $1,714,000 | -9.6% | 588,992 | 0.0% | 0.48% | -32.8% |
| Q4 2020 | $1,897,000 | – | 588,992 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |